Du P - Search Results

1

A selective and robust UPLC-MS/MS method for the simultaneous quantitative determination of anlotinib, ceritinib and ibrutinib in rat plasma and its application to a pharmacokinetic study.

Du P, Guan Y, An Z, Li P, Liu L. Du P, et al. Analyst. 2019 Sep 21;144(18):5462-5471. doi: 10.1039/c9an00861f. Epub 2019 Aug 5. Analyst. 2019. PMID: 31380858

2

Pharmacokinetics of Perfluorobutane after Intra-Venous Bolus Injection of Sonazoid in Healthy Chinese Volunteers.

Li P, Hoppmann S, Du P, Li H, Evans PM, Moestue SA, Yu W, Dong F, Liu H, Liu L. Li P, et al. Among authors: du p. Ultrasound Med Biol. 2017 May;43(5):1031-1039. doi: 10.1016/j.ultrasmedbio.2017.01.003. Epub 2017 Mar 7. Ultrasound Med Biol. 2017. PMID: 28283327 Free article.

3

Optimized UPLC-MS/MS method for the quantitation of olanzapine in human plasma: application to a bioequivalence study.

Du P, Li P, Zhao R, Liu H, Liu L. Du P, et al. Bioanalysis. 2019 Jun;11(13):1291-1302. doi: 10.4155/bio-2019-0114. Epub 2019 Aug 5. Bioanalysis. 2019. PMID: 31379195

4

Open-Label, Randomized, Single-Dose, 2-Period, 2-Sequence Crossover, Comparative Pharmacokinetic Study to Evaluate Bioequivalence of 2 Oral Formulations of Olanzapine Under Fasting and Fed Conditions.

Du P, Li P, Liu H, Zhao R, Zhao Z, Yu W, Zhou X, Liu L. Du P, et al. Clin Pharmacol Drug Dev. 2020 Jul;9(5):621-628. doi: 10.1002/cpdd.743. Epub 2019 Oct 8. Clin Pharmacol Drug Dev. 2020. PMID: 31595704 Clinical Trial.

5

In vitro and in vivo synergistic efficacy of ceritinib combined with programmed cell death ligand-1 inhibitor in anaplastic lymphoma kinase-rearranged non-small-cell lung cancer.

Du P, Hu T, An Z, Li P, Liu L. Du P, et al. Cancer Sci. 2020 Jun;111(6):1887-1898. doi: 10.1111/cas.14397. Epub 2020 May 22. Cancer Sci. 2020. PMID: 32227409 Free PMC article.

6

Simultaneous quantitative determination of arachidonic acid and cascade metabolites in rat serum by UPLC-MS/MS: application for longitudinal metabolomics of anlotinib.

Du P , Hu T , An Z , Li P , Liu L . Du P , et al. Analyst. 2020 Jul 21;145(14):4972-4981. doi: 10.1039/d0an00867b. Epub 2020 Jun 9. Analyst. 2020. PMID: 32515434

7

Longitudinal Pharmacometabonomics for Predicting Malignant Tumor Patient Responses to Anlotinib Therapy: Phenotype, Efficacy, and Toxicity.

Hu T, An Z, Sun Y, Wang X, Du P, Li P, Chi Y, Liu L. Hu T, et al. Among authors: du p. Front Oncol. 2020 Nov 12;10:548300. doi: 10.3389/fonc.2020.548300. eCollection 2020. Front Oncol. 2020. PMID: 33282726 Free PMC article.

8

Dual derivatization strategy for the comprehensive quantification and double bond location characterization of fatty acids by ultra-high performance liquid chromatography-tandem mass spectrometry.

Hu T, Sun Y, Li H, Du P, Liu L, An Z. Hu T, et al. Among authors: du p. J Chromatogr A. 2021 Feb 22;1639:461939. doi: 10.1016/j.chroma.2021.461939. Epub 2021 Jan 23. J Chromatogr A. 2021. PMID: 33530009

9

Quantitative HPLC-MS/MS determination of Nuc, the active metabolite of remdesivir, and its pharmacokinetics in rat.

Du P, Wang G, Yang S, Li P, Liu L. Du P, et al. Anal Bioanal Chem. 2021 Sep;413(23):5811-5820. doi: 10.1007/s00216-021-03561-8. Epub 2021 Jul 24. Anal Bioanal Chem. 2021. PMID: 34302183 Free PMC article.

10

Parallel derivatization strategy for comprehensive profiling of unconjugated and glycine-conjugated bile acids using Ultra-high performance liquid chromatography-tandem mass spectrometry.

Hu T, Li H, Xu B, Du P, Liu L, An Z. Hu T, et al. Among authors: du p. J Steroid Biochem Mol Biol. 2021 Nov;214:105986. doi: 10.1016/j.jsbmb.2021.105986. Epub 2021 Aug 25. J Steroid Biochem Mol Biol. 2021. PMID: 34454009

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,826 results

Search Page

Filters